Bank supports Mironid with £8.4m in race to commercial success
Mironid, a Glasgow-based biopharmaceutical company, employing 16 staff including scientists, has secured an £8.4m equity investment from the Scottish National Investment Bank. This gives the company further breathing space to...
Real-time hormone tracker raises £1.2m to tackle women’s health
An Edinburgh spin-out able to measure human hormone levels in real time has secured £1.2m to investigate women’s hormone-related conditions and support better diagnosis and treatment. Kāhu SiliconBio, founded by scientists...
SCOTLAND V CAMBRIDGE: Bid to bring £100m in-vitro life science hub to Edinburgh
Our resistance to harmful microbes remains one of humanity’s greatest challenges. In many cases, the rise of diseases has been compounded by changing climate conditions.Scotland’s life science communities are playing...
Screen stars of microfluidic technology aim for next level
How Michele Zagnoni and Alex Sim are taking Screenin3D to the next level Dr Michele Zagnoni, born and educated in Bologna, is a new-generation Glaswegian making a difference in his...
Health tech Bioliberty secures total Series A funding of £7.7m
Bioliberty — a health technology start-up spanning Edinburgh and Boston — has secured a helping hand of £7.7m over the last ten months for vital Series A funding.The company, which...
Biotech spin-out secures £1.58m as bio kits sell in US
BIOCAPTIVA, a University of Edinburgh spin-out, has raised £1.58m in funding as it launches its first product in the United States.The spin-out, based in the Roslin Innovation Centre at Easter...
Scotland’s acute shortage of lab space given further injection of multi-million funding
An acute shortage of lab space for Scotland’s vital life science industry is being tackled in Glasgow.Glasgow City Region has launched a further £20m fund dedicated to expanding the amount...
Angels who give wings to Scotland’s innovators
The purchase of medical diagnostics firm Blackford Analysis by Bayer is one of the best examples of how Scotland’s angel network works – but there are many others Bayer, the...
Clinical trials offer healthy potential for Scotland
As participation in clinical research falls, Alison Culpan Director of the ABPI in Scotland looks at why Scotland should be investing in this multi-million pound activity. Phase 3 clinical trials,...
‘Our role is to get the ideas out of the university’
Collaboration between academia, government and the NHS is crucial in the life sciences sector – and that’s where Edinburgh Innovations comes in We have come a long way from the...